Human CXCL14/BRAK Antibody, R&D Systems™

CXCL14/BRAK

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

BMAC, Bolekine, BRAK, BRAKKEC, chemokine (C-X-C motif) ligand 14, Chemokine BRAK, CXC-X3, member 14 (BRAK), MIP-2 gamma, MIP2G, MIP-2G, NJACKec, SCYB14MGC10687, Small-inducible cytokine B14

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

9547

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2a

Western Blot, ELISA

131120

Western Blot 1 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

O95715

CXCL14

E. coli-derived recombinant human CXCL14/BRAK Leu23-Tyr99 Accession # O95715

500 μg

Primary

Detects human CXCL14/BRAK in ELISAs and Western blots. In direct ELISAs, shows approximately 80% cross-reactivity with recombinant mouse (rm) CXCL14/BRAK and no cross-reactivity with recombinant human (rh)GRO alpha , rhGRO beta , rhGRO gamma ,rhMIP-1 alpha , rmMIP-1 alpha , rmMIP-1 beta , rhMIP-1 delta , rmMIP-1 gamma , rmMIP-2, rhMIP-3 alpha , rmMIP-3 alpha , rrMIP-3 alpha , rhMIP-3 beta , or rmMIP-3 beta .

Human

Purified